摘要
近40年来,我国膀胱癌诊治理念与技术发展迅速,临床和基础研究得到长足的进步。我们在膀胱癌无创诊断、微创治疗、肿瘤综合治疗及基础研究等领域取得丰硕的成果。同时,我们也应清醒地认识到我国膀胱癌研究与国际顶尖水平仍有差距,缺乏有影响力的高质量研究成果。未来,我们应充分利用临床资源,大力开展多中心前瞻性随机对照研究及真实世界研究,推进多学科交叉合作,促进研究成果临床转化,最终推进我国膀胱癌整体诊疗水平。
In the past 40 years,the concept and technology of diagnosis and treatment of bladder cancer have developed rapidly in China.We have achieved fruitful results in the research fields of noninvasive diagnosis,minimally invasive surgery,comprehensive treatment and basic research of bladder cancer.At the same time,we aware that the research on bladder cancer in our country is still in a follow-up state,with few influential and high-quality research.In the future,we should make more use of the clinical resources to conduct multi-center research involving prospective randomized controlled study and real-world study.We should also promote multidisciplinary cooperation,nourish the translational research conditions,and ultimately promote the level of diagnosis and treatment of bladder cancer in China.
作者
林天歆
黄健
Lin Tianxin;Huang Jian(Department of Urology,Sun Yat-sen Memorial Hospital,Sun Yat-sen University,Guangzhou 510120,China)
出处
《中华泌尿外科杂志》
CAS
CSCD
北大核心
2020年第8期561-565,共5页
Chinese Journal of Urology
关键词
膀胱癌
临床研究
多中心
基础研究
Bladder cancer
Clinical research,multicenter
Fundamental research